Gurudatta Naik Selected Research

Androgen Receptors (Androgen Receptor)

1/2019	Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
1/2017	Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gurudatta Naik Research Topics

Disease

17	Neoplasms (Cancer) 10/2021 - 01/2015
7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2014
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2015
5	Carcinoma (Carcinomatosis) 10/2020 - 10/2015
5	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 03/2017
1	Neutropenia 10/2021
1	Hypotension (Low Blood Pressure) 10/2021
1	Anemia 10/2021
1	Adenocarcinoma 04/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2021
1	Onchocerciasis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Diarrhea 11/2020
1	Fatigue 11/2020
1	Hypertension (High Blood Pressure) 11/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Disease Progression 01/2018
1	Penile Neoplasms (Penile Cancer) 01/2018
1	Extranodal Extension 04/2017
1	Rare Diseases (Rare Disease) 01/2016
1	Pancreatitis 04/2015

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2015
3	Peptides (Polypeptides)IBA 10/2021 - 01/2015
3	Circulating Tumor DNAIBA 10/2020 - 01/2018
3	Cell-Free Nucleic AcidsIBA 10/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	Alkaline PhosphataseIBA 10/2021 - 11/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 04/2015
1	Leucovorin (Folinic Acid)FDA Link 04/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2021
1	Fluorouracil (Carac)FDA LinkGeneric 04/2021
1	Ivermectin (Mectizan)FDA Link 01/2021
1	BNC 105PIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	merestinibIBA 11/2020
1	RamucirumabIBA 11/2020
1	Threonine (L-Threonine)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	CateninsIBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Neurofibromin 1 (Neurofibromin)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Serine (L-Serine)FDA Link 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2017
1	GSK2256098IBA 04/2017
1	Biological ProductsIBA 04/2017
1	Tyrosine (L-Tyrosine)FDA Link 04/2017
1	Focal Adhesion Kinase 1IBA 04/2017
1	Hormones (Hormone)IBA 01/2017
1	EndostatinsIBA 01/2017
1	AndrogensIBA 01/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017
1	Gemcitabine FDA Link 04/2016
1	PlatinumIBA 04/2016
1	Taxoids (Taxanes)IBA 04/2016
1	taxaneIBA 04/2016
1	Aurora Kinase AIBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 04/2015
1	Prednisone (Sone)FDA LinkGeneric 06/2014
1	C-Reactive ProteinIBA 01/2014

Therapy/Procedure

9	Therapeutics 04/2021 - 04/2016
3	Drug Therapy (Chemotherapy) 01/2020 - 04/2016
3	Castration 01/2019 - 06/2014
2	Precision Medicine 01/2020 - 10/2015
2	Nephrectomy 01/2019 - 01/2018
1	Mass Drug Administration 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2017
1	Salvage Therapy 01/2016
1	Cystectomy 10/2015